So of course we had lots of questions, of course, like, so the POTS patients wanna know, is it okay in people with POTS and the EDS patients and the ME/CFS patients, everybody wants to know like, is it okay to, with their comorbid conditions
Body Pharm BPC-157 + TB-500 Pen: Product Specification The Body Pharm BPC-157 + TB-500 pen is a pre-mixed, sealed research injection device containing both peptides co-dissolved at a fixed ratio, supplied with a batch-specific Certificate of Analysis and shipped under refrigerated conditions for UK research use only
See also Expert Panel for Delimitation Questions Report regarding suspected illegal trading in medicinal products Address for enquiries Swissmedic Media Unit
Some animal studies have indicated that chronic exposure to these medications may lead to thyroid C-cell hyperplasia and tumours
And those with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasias should not use them
Energy normalized